CellPly Company
Developing analytical systems to characterize next-generation cancer immunotherapy
Founded Date:
2013-01-01
Technology:
Biotechnology, Health Care, Medical
Funding Status:
Seed
Total Funding:
6690000.0
Employee Number:
1-10
Headquarters:
Bologna, Emilia-Romagna, Italy
Last Funding Date:
2021-12-15
Investors Number:
8.0
Last Funding Type:
Venture - Series Unknown
Estimated Revenue:
$1M to $10M
Industry:
Preclinical Development